Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Simultaneous Measurement of Hydrogen and Methane Improves Diagnostic Yield in the Diagnosis of Intestinal Microbial Overgrowth].

Acta gastroenterologica Latinoamericana·2025
Same author

Rome Foundation and international neurogastroenterology and motility societies' consensus on idiopathic gastroparesis.

The lancet. Gastroenterology & hepatology·2024
Same author

Prevalence of extra-intestinal symptoms according to irritable bowel syndrome subtype.

Neurogastroenterology and motility·2024
Same author

Superficial oesophageal mucosal innervation may contribute to severity of symptoms in oesophageal motility disorders.

Alimentary pharmacology & therapeutics·2023
Same author

Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.

Digestive diseases (Basel, Switzerland)·2023
Same author

Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis.

Gastroenterologia y hepatologia·2022
Same journal

[Solid Pseudopapillary Neoplasm of the Pancreas: Diagnosis and Surgical Management in a Young Patient].

Acta gastroenterologica Latinoamericana·2026
Same journal

Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Are They Overdiagnosed?

Acta gastroenterologica Latinoamericana·2026
Same journal

Pancreatic Atypical Neurofibromatous Neoplasm with Uncertain Biological Potential (ANNUBP) Mimicking a Solid Pseudopapillary Tumor Pancreatic ANNUBP.

Acta gastroenterologica Latinoamericana·2026
Same journal

[Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Association with Disease Activity and its Impact on Quality of Life].

Acta gastroenterologica Latinoamericana·2026
Same journal

Acta gastroenterologica Latinoamericana·2026
Same journal

[Use of Los Angeles Classification in Erosive Esophagitis: analysis of inter-observer and intra-observer agreement].

Acta gastroenterologica Latinoamericana·2026
See all related articles

Related Experiment Video

Updated: Jul 7, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

[Diagnostic and therapeutic algorithm in functional dyspepsia].

Guido Iantorno1, Rodolfo Corti, Luis María Bustos Fernández

  • 1Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo Buenos Aires, Argentina. guidoiantorno@yahoo.com.ar

Acta Gastroenterologica Latinoamericana
|February 16, 2008
PubMed
Summary
This summary is machine-generated.

A national consensus established a diagnostic and therapeutic algorithm for functional dyspepsia, prioritizing patient-provider relationships and symptom-based treatment pathways for improved digestive health outcomes.

Related Experiment Videos

Last Updated: Jul 7, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Practice Guidelines

Background:

  • Dyspepsia, characterized by indigestion, necessitates a unified approach due to its complex, multidisciplinary nature.
  • A national consensus aimed to establish a standardized diagnostic and therapeutic algorithm for functional dyspepsia.

Framework:

  • The algorithm prioritizes the medical-patient relationship and patient reassurance.
  • It stratifies patients based on the presence or absence of alarm signs.

Implementation:

  • Patients without alarm signs are categorized by primary symptoms: pain or epigastric discomfort.
  • Diagnostic workup includes endoscopy and abdominal ultrasound for pain-dominant dyspepsia.
  • Therapeutic testing guides treatment for negative studies or discomfort-dominant dyspepsia, involving H2 blockers, PPIs, prokinetics, antidepressants, calcium channel blockers, and other agents.

Implications:

  • This consensus provides a structured, evidence-based framework for managing functional dyspepsia nationally.
  • It facilitates consistent patient care and optimizes therapeutic interventions.
  • The algorithm addresses the need for psychological support in refractory cases, promoting holistic patient management.